Regulator approves Australian-manufactured COVID-19 vaccines

Australia's medical regulator has approved the domestically-produced AstraZeneca coronavirus vaccines.

The Therapeutic Goods Administration (TGA) on Sunday night announced the approval of the doses of the University of Oxford/AstraZeneca COVID-19 vaccine manufactured in Melbourne by biotechnology company CSL.

In a statement it described the approval as a "critical and very exciting milestone" in Australia's pandemic response.

"Specific approval of Australian manufacturing by TGA was required to ensure that the locally-manufactured vaccine had exactly the same composition and performance as overseas-manufactured vaccine, was made to the same quality and is free of contaminants," it said.

Australia has agreed to acquire 53.8 million doses of the AstraZeneca vaccine, 50 million of which will be produced by CSL.

The TGA said that the first domestically-produced vaccines were expected to be released "in the next few days."

Greg Hunt, the minister for health, said it was a "critical next step."

"It means the manufacturing process for CSL has been approved, it's safe, it's effective," he told Australian Broadcasting Corporation (ABC) television.

The approval is expected to significantly accelerate the speed of the vaccine rollout in Australia.

More than 6 million Australians became eligible to receive vaccines from Monday under phase 1B of the rollout, which covers the elderly, critical workers and people with underlying health conditions.

As of Sunday afternoon, there had been 29,196 confirmed cases of COVID-19 in Australia, and the numbers of locally and overseas acquired cases in the last 24 hours were zero and four respectively, according to the latest figures updated on Sunday evening from the Department of Health.